ArticleFrontiers in endocrinology2025
Correlation of the triglyceride-glucose index with major adverse cardiovascular events in type 2 diabetes mellitus patients with acute myocardial infarction combined with HFpEF.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: This study was conducted to evaluate the correlation between triglyceride-glucose index (TyG) and major adverse cardiovascular events (MACE) in patients with type 2 diabetes mellitus (T2DM) and heart failure with preserved ejection fraction (HFpEF) after acute myocardial infarction (AMI). Methods: This retrospective study at the First Affiliated Hospital of Dalian Medical University included 400 AMI patients with T2DM and HFpEF who underwent percutaneous coronary intervention (PCI) between 1 January 2018 and 1 January 2023. The study was conducted using univariate and multivariate Cox regression analyses, subgroup analyses, receiver operating characteristic (ROC) curves, and Kaplan-Meier survival curves to assess the correlation between the TyG index and MACE. Results: Multivariate Cox regression analyses showed that in model 3 with variables fully adjusted, when TyG was used as a categorical variable, the risk of MACE in the TyG T2 and T3 groups was 1.622 times and 2.247 times higher than that in the T1 group, respectively ( Conclusions: The TyG index was independently associated with MACE in T2DM patients with AMI combined with HFpEF.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.